These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 34480615)

  • 61. Incidence and dynamics of Epstein-Barr virus reactivation after alemtuzumab-based conditioning for allogeneic hematopoietic stem-cell transplantation.
    Carpenter B; Haque T; Dimopoulou M; Atkinson C; Roughton M; Grace S; Denovan S; Fielding A; Kottaridis PD; Griffiths P; Mackinnon S; Emery V; Chakraverty R
    Transplantation; 2010 Sep; 90(5):564-70. PubMed ID: 20555307
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical Analysis of Epstein-Barr Virus Infection after Allogeneic Hematopoietic Stem Cell Transplantation].
    Liu LX; Wang J; Wang L; Liu L; Wang X; Zhang HB; Tang XQ; Xiong YY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug; 32(4):1217-1223. PubMed ID: 39192423
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reactivation and dynamics of cytomegalovirus and Epstein-Barr virus after rabbit antithymocyte globulin and cyclosporine for aplastic anemia.
    Park SS; Cho SY; Han E; Min GJ; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Cho SG; Lee JW
    Eur J Haematol; 2019 Oct; 103(4):433-441. PubMed ID: 31381187
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.
    van Esser JW; van der Holt B; Meijer E; Niesters HG; Trenschel R; Thijsen SF; van Loon AM; Frassoni F; Bacigalupo A; Schaefer UW; Osterhaus AD; Gratama JW; Löwenberg B; Verdonck LF; Cornelissen JJ
    Blood; 2001 Aug; 98(4):972-8. PubMed ID: 11493441
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Alterations in NKG2A and NKG2C Subsets of Natural Killer Cells Following Epstein-Barr Virus Reactivation in CTLA4Ig-based Haploidentical Transplantation Is Associated With Increased Chronic Graft-Versus-Host Disease.
    Jaiswal SR; Bhakuni P; Bhagwati G; Aiyar HM; Chakrabarti A; Chakrabarti S
    Transplantation; 2020 Jan; 104(1):e23-e30. PubMed ID: 31478993
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study.
    Gerbitz A; Gary R; Aigner M; Moosmann A; Kremer A; Schmid C; Hirschbuehl K; Wagner E; Hauptrock B; Teschner D; Roesler W; Spriewald B; Tischer J; Moi S; Balzer H; Schaffer S; Bausenwein J; Wagner A; Schmidt F; Brestrich J; Ullrich B; Maas S; Herold S; Strobel J; Zimmermann R; Weisbach V; Hansmann L; Lammoglia-Cobo F; Remberger M; Stelljes M; Ayuk F; Zeiser R; Mackensen A
    Front Immunol; 2023; 14():1251593. PubMed ID: 37965339
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation.
    Nakamae H; Kirby KA; Sandmaier BM; Norasetthada L; Maloney DG; Maris MB; Davis C; Corey L; Storb R; Boeckh M
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):694-703. PubMed ID: 19450754
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of prophylaxis with rituximab on EBV-related complications after allogeneic hematopoietic cell transplantation in children.
    Marjańska A; Pogorzała M; Dziedzic M; Czyżewski K; Richert-Przygońska M; Dębski R; Bogiel T; Styczyński J
    Front Immunol; 2024; 15():1427637. PubMed ID: 39055711
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reactivation of EBV and CMV in Severe COVID-19-Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients.
    Naendrup JH; Garcia Borrega J; Eichenauer DA; Shimabukuro-Vornhagen A; Kochanek M; Böll B
    J Intensive Care Med; 2022 Sep; 37(9):1152-1158. PubMed ID: 34791940
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Controlled Epstein-Barr virus reactivation after allogeneic transplantation is associated with improved survival.
    Auger S; Orsini M; Céballos P; Fegueux N; Kanouni T; Caumes B; Klein B; Villalba M; Rossi JF
    Eur J Haematol; 2014; 92(5):421-8. PubMed ID: 24400833
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Single dose versus multiple doses of rituximab for preemptive therapy of Epstein-Barr virus reactivation after hematopoietic cell transplantation.
    Jain T; Kosiorek HE; Grys TE; Kung ST; Shah VS; Betcher JA; Slack JL; Leis JF; Khera N; Noel P; Palmer JM; Sproat LZ
    Leuk Lymphoma; 2019 Jan; 60(1):110-117. PubMed ID: 29979906
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus.
    Liu YC; Lu PL; Hsiao HH; Chang CS; Liu TC; Yang WC; Lin SF
    Ann Hematol; 2012 Apr; 91(4):587-95. PubMed ID: 21997849
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant.
    Jiang W; Clancy LE; Avdic S; Sutrave G; Street J; Simms R; McGuire HM; Patrick E; Chan AS; McCaughan G; Myers N; Micklethwaite KP; Antonenas V; Selim AG; Ritchie D; Bateman CM; Shaw PJ; Blyth E; Gottlieb DJ
    Blood Adv; 2022 Sep; 6(17):4949-4966. PubMed ID: 35819448
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Outcome of Rituximab-Based Treatment for Post-Transplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience.
    Zhu CY; Zhao SS; Wang XK; Wang L; Wang FY; Fang S; Liu ZX; Guan LX; Liu YC; Ding Y; Dou LP; Wang LL; Gao CJ
    Ann Transplant; 2019 Apr; 24():175-184. PubMed ID: 30940797
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Letermovir as secondary prophylaxis of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: A single center experience.
    Desai N; Pasic I; Law AD; Lam W; Gerbitz A; Viswabandya A; Kim DD; Kumar R; Mattsson J; Novitzky-Basso I; Michelis FV
    Eur J Haematol; 2024 Oct; 113(4):477-484. PubMed ID: 39031870
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of CMV and EBV on Immune Recovery After Allogeneic Hematopoietic Cell Transplantation in Children.
    Pukownik E; Kubicka M; Kurylo-Rafinska B; Debski R; Galazka P; Czyzewski K; Krenska A; Bartoszewicz N; Demidowicz E; Marjańska A; Dziedzic M; Pogorzala M; Wysocki M; Styczynski J
    Anticancer Res; 2018 Oct; 38(10):6009-6013. PubMed ID: 30275233
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimen.
    Manjappa S; Bhamidipati PK; Stokerl-Goldstein KE; DiPersio JF; Uy GL; Westervelt P; Liu J; Schroeder MA; Vij R; Abboud CN; Fehniger TA; Cashen AF; Pusic I; Jacoby M; Meera SJ; Romee R
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):46-52. PubMed ID: 24120526
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of early EBV and/or CMV viremia on graft function and acute cellular rejection in pediatric liver transplantation.
    Indolfi G; Heaton N; Smith M; Mieli-Vergani G; Zuckerman M
    Clin Transplant; 2012; 26(1):E55-61. PubMed ID: 21981027
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Herpesvirus infections in hematopoietic stem cell transplant recipients seropositive for human cytomegalovirus before transplantation.
    Fan J; Jing M; Yang M; Xu L; Liang H; Huang Y; Yang R; Gui G; Wang H; Gong S; Wang J; Zhang X; Zhao H; Gao H; Dong H; Ma W; Hu J
    Int J Infect Dis; 2016 May; 46():89-93. PubMed ID: 27057748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.